Phreesia (PHR) Insider Jon Kessler Buys $185K of Stock
Jon Kessler made a significant purchase of Phreesia shares on June 24, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Jon Kessler bought 19,290 shares of Phreesia, Inc. ($PHR) at an average price of $9.59, worth about $184,991.10, on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $PHR is up 11.8% after 1 week, up 6.6% after 1 month and up 14.1% to date (from the $9.59 close on Jun 24, 2026).
PHR
Phreesia, Inc.
Key Points
- Jon Kessler bought 19,290 shares of Phreesia, Inc. for about $184,991 at a price of $9.59 each on June 24, 2026.
- Phreesia, Inc. shares recently traded at $9.13, down from a previous close of $10.04, reflecting market volatility.
- The company has a market cap of approximately $622.6 million and a forward P/E ratio of 6.24.
Get $PHR trade alerts by text
We text you when insiders, Congress or big funds trade $PHR. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Phreesia, Inc. alert may contain errors. Disclosures
Kessler's Recent Purchase
Jon Kessler bought 19,290 shares of Phreesia, Inc. (NYSE: PHR) for about $184,991 on June 24, 2026. This purchase was made at a price of $9.59 per share. The stock closed at $10.04 the previous day, showing a notable drop in value since then.
Insider Buying and Selling at Phreesia, Inc.
Kessler's transaction is part of a larger trend of insider buying at Phreesia. On the same day, several other insiders also bought 19,290 shares each at the same price. This includes Gillian Munson, Lisa Egbuonu-Davis, Ramin Sayar, Smith Mark Douglas, and Lainie Goldstein, all making similar investments valued at approximately $185,000 each. This coordinated buying suggests a collective confidence among the company's leadership.
How Phreesia, Inc. Stock Has Traded
The stock is currently trading at $9.13, significantly below its 52-week high of $25.00. This decline may offer insights into market sentiment around Phreesia, especially following the recent insider purchases, which could be viewed as a bullish signal by investors.
Recent Earnings
Phreesia, Inc. reported revenue of about $507.8 million, showing a growth rate of 10.4%. The company’s earnings per share (EPS) stands at $0.18, with a net margin of 2.1%. The next earnings report is expected on December 7, 2026.
Analysts Set New Price Targets
Analysts have mixed views on Phreesia. On October 12, 2026, Barclays maintained an Equal-Weight rating with a price target of $11.00. Meanwhile, Raymond James downgraded the stock to Market Perform on September 8, 2026, reflecting caution in the current market environment. The average target price among analysts is $13.94, suggesting room for growth from current levels.
What Phreesia, Inc. Does
Phreesia, Inc. provides a software and payment platform tailored for the healthcare industry, helping organizations with patient engagement and financial solutions. The recent insider buying may indicate confidence in the company’s future performance, despite current market challenges.
What to Watch at Phreesia, Inc.
Investors should keep an eye on Phreesia's next earnings report on December 7, 2026, to gauge the company's performance and market response. The recent insider transactions may also provide insight into the management's outlook on the company's prospects as they navigate current market conditions.
Related Filing Alerts
Source: Jon Kessler's Form 4 filing on $PHR (Jun 24, 2026). Find the original filing: PHR Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts